Discover
CTXR
Citius Pharmaceuticals, Inc.
0.55
1 x 0.48
1 x 0.61
bid
ask
+
0.06
13.50%
200 @ 08:03 AM
0.56 +0.01 (2.66%)
| Ytd | -29.79% | |
| 1y | -62.12% |
0.49
day range
0.58
0.47
52 week range
2.19
| Open | 0.49 | Prev Close | 0.48 | Low | 0.49 | High | 0.58 | Mkt Cap | 6.10M |
| Vol | 1.91M | Avg Vol | 637.86K | EPS | -2.57 | P/E | -0.21 | Forward P/E | 15.32 |
| Beta | 0.98 | Short Ratio | 1.23 | Inst. Own | 13.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.59 | 200-d Avg | 0.89 | 1yr Est | 54.00 |
| Income Statement | |||
| Total Revenue | 1.67M | ||
| Revenues (USD) | 1.67M | ||
| Cost of Revenue | 328.88K | ||
| Gross Profit | 1.34M | ||
| Operating Expenses | 33.53M | ||
| Research and Development Expense | 1.63M | ||
| Selling, General and Administrative Expense | 26.39M | ||
| Operating Income | -32.19M | ||
| Interest Expense | 33.03K | ||
| Income Tax Expense | -231.21K | ||
| Net Income | -21.23M | ||
| Net Income Common Stock | -21.23M | ||
| Net Income Common Stock (USD) | -21.23M | ||
| Consolidated Income | -28.11M | ||
| Net Income to Non-Controlling Interests | -6.88M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.95 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -21.43M | ||
| Earning Before Interest & Taxes (USD) | -21.43M | ||
| Weighted Average Shares | 22.38M | ||
| Weighted Average Shares Diluted | 22.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.63M | ||
| Cash and Equivalents (USD) | 4.63M | ||
| Trade and Non-Trade Receivables | 1.08M | ||
| Current Assets | 31.69M | ||
| Property, Plant & Equipment Net | 794.52K | ||
| Total Assets | 132.54M | ||
| Debt Current | 171.50K | ||
| Total Debt | 808.16K | ||
| Current Liabilities | 55.02M | ||
| Debt Non-Current | 636.67K | ||
| Total Liabilities | 63.46M | ||
| Accumulated Retained Earnings (Deficit) | -268.26M | ||
| Shareholders Equity | 61.54M | ||
| Shareholders Equity (USD) | 61.54M | ||
| Assets Non-Current | 100.85M | ||
| Total Debt (USD) | 808.16K | ||
| Goodwill and Intangible Assets | 9.35M | ||
| Inventory | 22.66M | ||
| Liabilities Non-Current | 8.44M | ||
| Trade and Non-Trade Payables | 27.10M | ||
| Tax Liabilities | 7.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 40.66K | ||
| Net Cash Flow from Financing | -1.23M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.13M | ||
| Capital Expenditure | -600.00K | ||
| Issuance (Purchase) of Equity Shares | -62.76K | ||
| Issuance (Repayment) of Debt Securities | -1000.00K | ||
| Net Cash Flow from Investing | -600.00K | ||
| Net Cash Flow from Operations | -1.30M | ||
| Share Based Compensation | 3.79M | ||